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Abstract
Background: Plasmodium falciparum malaria is a significant problem around the world today, thus there is still a
need for new control methods to be developed. Because the sporozoite displays dual infectivity for both the
mosquito salivary glands and vertebrate host tissue, it is a good target for vaccine development.
Methods: The P. falciparum gene, PF11_0394, was chosen as a candidate for study due to its potential role in the
invasion of host tissues. This gene, which was selected using a data mining approach from PlasmoDB, is expressed
both at the transcriptional and protein levels in sporozoites and likely encodes a putative surface protein. Using
reverse transcription-polymerase chain reaction (RT-PCR) and green fluorescent protein (GFP)-trafficking studies, a
transcript and protein expression profile of PF11_0394 was determined.
Results: The PF11_0394 protein has orthologs in other Plasmodium species and Apicomplexans, but none outside
of the group Apicomplexa. PF11_0394 transcript was found to be present during both the sporozoite and
erythrocytic stages of the parasite life cycle, but no transcript was detected during axenic exoerythrocytic stages.
Despite the presence of transcript throughout several life cycle stages, the PF11_0394 protein was only detected in
salivary gland sporozoites.
Conclusions: PF11_0394 appears to be a protein uniquely detected in salivary gland sporozoites. Even though a
specific function of PF11_0394 has not been determined in P. falciparum biology, it could be another candidate for
a new vaccine.
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Background
Malaria is still a major problem around the world due to
the development of insecticide-resistant mosquitoes, drug-
resistant Plasmodium parasites, and economic/political
instability in areas of the world where malaria is a signifi-
cant problem [1]. It is estimated that 225 million cases of
malaria occur annually and, of those, 750,000 are fatal
[2,3]. Because of these issues, it is critical for improved
and/or new malaria control methods to be developed. The
Plasmodium falciparum gene, PF11_0394, was chosen as a
candidate for study due to its potential role in the invasion
of host tissues based on an in silico data mining protocol.
PF11_0394 was selected based on data collected from Plas-
moDB, the Plasmodium database, indicating that this gene
likely encodes a putative surface protein, and is present in
the sporozoite both at the mRNA transcript and protein
levels [4-7]. These specific criteria were set for two
reasons: first, not many sporozoite proteins are well char-
acterized based on the difficulty of working with P. falci-
parum mosquito stages in a laboratory setting and,
second, many Plasmodium proteins that have been shown
to be critical for invasion and/or development of the
parasite are surface or secreted proteins, including the
sporozoite proteins, circumsporozoite (CS) protein and
thrombospondin-related anonymous protein (TRAP)
[8-10].
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gene, PF11_0394, at the transcript and protein levels to
determine its expression profile during various life cycle
stages. Using reverse transcriptase-polymerase chain reac-
tion (RT-PCR) and green fluorescent protein (GFP)-traf-
ficking studies, it was determined that PF11_0394 has
transcript present during several life cycle stages, but its
protein is only detected during the salivary gland sporo-
zoite stage.
Methods
Parasite maintenance, parasite transmission, and cell
cultures
Plasmodium falciparum strain NF54 was used for the
following experiments and was maintained according to
procedures described by Carter and colleagues [11].
Briefly, P. falciparum cultures were maintained in human
blood (O + male, BioChemed Services) at a 6% haemato-
crit in complete culture medium, RPMI 1640 (Gibco)
supplemented with 25 mM HEPES (Gibco), 0.5% Albu-
max (Invitrogen), and 0.005% hypoxanthine (Sigma). The
medium was changed every 48 hours and the parasites
were kept in a gas mixture (3% O2,3 %C O 2, and 94% N2)
at 37°C [11]. Cultures were diluted/split to prevent the
parasitaemia from becoming too high by addition of
fresh, washed 50% blood (blood washed three times with
sterile RPMI and diluted 50:50 with RPMI), maintaining
a 6% haematocrit level. The use of human blood was in
compliance with federal guidelines and institutional poli-
cies. All experiments described in this paper were
approved by the Institutional Biosafety Committee (IBC),
the Institutional Review Board (IRB), and the University
of Missouri Institutional Animal Care and Use Commit-
tee (IACUC).
In order to obtain infected mosquitoes to study the
parasite stages within the vector host, four-five day old,
female Anopheles stephensi were exposed to P. falci-
parum-infected blood (1:1 ratio of infected blood and
human serum), using induced gametocyte cultures.
Gametocyte cultures were produced by setting a standard
culture (described above) at a parasitaemia of between
0.5-1.0% and maintaining them in complete culture
media supplemented with 10% human serum (A + male,
Interstate Blood Bank); however, instead of splitting the
parasites with fresh red blood cells (RBCs), the culture
was left undiluted such that a high parasitaemia devel-
oped and the parasites became stressed. This was done
for 16 days and resulted in a mixture of male and female
gametocyte stages (I-V), with a majority of them being
mature stages. The mosquitoes were fed the infected
blood for approximately 30 minutes, using a 37°C water-
jacketed membrane feeding system. After the blood feed,
only colony cages where at least 75% of females fed were
utilized and the infected mosquitoes were maintained in
an incubator (Low Temperature Illuminated Incubator
818, Precision) at 26-27°C with 82-88% humidity.
To obtain exoerythrocytic stages, axenic cultures (pro-
ducing liver stage parasites without hepatocytes) were uti-
lized and were produced by following an online protocol
by Kappe and colleagues [12]. In brief, approximately 5 ×
10
4 salivary gland sporozoites were added to a well of a
48-well plate (Corning) and allowed to incubate in RPMI
1640 medium (Invitrogen) supplemented with 10% foetal
bovine serum (Hyclone) and 500 units/ml and 500 μg/ml
penicillin and streptomycin, respectively. These cultures
were maintained in a 37°C incubator with 5% CO2 for
24 hours before collection for transcript expression studies
[12].
Mosquito maintenance
Anopheles stephensi were used for all studies. Mosquitoes
were reared using protocols available from the Malaria
Research and Reference Reagent Resource Center (MR4).
In brief, larvae and adults were maintained in an insectary
with 78-85% humidity at approximately 26-27°C on a
12-hour light/dark cycle. Larvae were fed both a mixture
of 0.33 g yeast (Fleischmann’s) and 0.66 g micron (Sera)
per 50 ml water and game fish chow (Purina). Adults were
fed sucrose (0.3 M) ad libitum.
Selection of candidate gene, PF11_0394
An in silico data mining procedure was used to select
PF11_0394 as a gene of interest. Briefly, PlasmoDB was
utilized to search for P. falciparum proteins predicted to
be expressed only by the sporozoite and containing a sig-
nal peptide, increasing its probability of being a surface
protein [6,13]. Next, additional sequence analysis pro-
grams available on the ExPASy Bioinformatics Resource
Portal and SoftBerry, such as PSORT and ProtComp, were
used to verify that the proteins encoded by the genes were
predicted to either be located on the surface and/or
secreted by the parasite [14,15]. Those proteins that were
verified by these two programs to meet the required cri-
teria (and were not proteins that had been studied or were
currently being studied) became the genes of interest,
including PF11_0394.
PF11_0394 sequence analysis
Using PlasmoDB, the full genomic DNA (gDNA), com-
plimentary DNA (cDNA), and protein sequence of
PF11_0394 were obtained. A list of orthologs of
PF11_0394 was compiled using both PlasmoDB and
the National Center for Biotechnology Information’s
(NCBI) BLAST analysis program [16]. The ortholog
sequences were then aligned using Vector NTI
(Explorer or Contig Express, Invitrogen). Additional
sequence information for PF11_0394 was obtained by
using software programs such as TargetP, SignalP,
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the ExPASy Bioinformatics Resource Portal [14,15,17].
Isolation of Plasmodium falciparum-infected tissues for
transcript expression studies
Oocyst sporozoites
Anopheles stephensi were infected with P. falciparum as
described previously. Ten days post-infection (PI), when
oocyst sporozoites were mature using laboratory condi-
tions, 50 mid-guts were dissected from the abdomens of
An. stephensi that had fed on a P. falciparum-infected
blood meal. The tissues were placed in 50 μlI Xp h o s -
phate buffered saline (10X PBS, 0.2 M phosphate buffer
and 1.5 M NaCl pH 7.0, diluted 1:10 with Millipore
water) in microcentrifuge tubes, snap-frozen in liquid
nitrogen, and stored at-80°CCutil needed for RNA
isolation.
Salivary gland sporozoites
Fifty sets of An. stephensi salivary glands were dissected
from mosquitoes that had fed on a P. falciparum-infected
blood meal 14 days PI because sporozoites are found in
the glands at this time under laboratory conditions. The
tissues were put in 50 μl 1X PBS in microcentrifuge tubes,
s n a p - f r o z e ni nl i q u i dn i t r o g e n ,a n ds t o r e da t- 8 0 ° Cu n t i l
needed for RNA isolation.
Exoerythrocytic stages
Axenic exoerythrocytic stages were generated as pre-
viously described. After 24 hours, Trizol (Invitrogen)
was directly added to the cultures to begin the process
of RNA isolation.
Mixed erythrocytic stages and gametocytes
Plasmodium falciparum cultures were maintained as pre-
viously described. Either mixed erythrocytic stage (ES) cul-
tures (containing a mixture of rings, trophozoites, and
schizonts) or 16-day-old mixed gametocyte cultures (con-
taining a mixture of stage I-V gametocytes, but with more
mature forms present) were collected by centrifugation at
2,650 × g for five minutes. The infected RBCs were lyzed
with 0.05% saponin (Invitrogen) in complete culture med-
ium for three minutes at room temperature (RT) and
parasites collected by centrifugation for five minutes at
2,650 × g. Purified parasites were then washed once with
RPMI 1640 medium and collected again by centrifugation
as previously described. The parasite pellets were stored at
-80°C until needed for RNA isolation.
RNA/DNA isolation and transcriptional analysis by reverse
transcription-polymerase chain reaction (RT-PCR)
Total RNA was isolated from Plasmodium-infected tissues
using a Trizol reagent-based protocol, following the manu-
facturer’s instructions (Invitrogen). The samples were all
DNase-treated (Promega), according to the manufacturer’s
instructions, to remove any contaminating gDNA.
Approximately 2-3 μg of the DNase-treated RNA was
used to synthesize cDNA using OligoDT primers from a
SuperScript™ III First-Strand Synthesis System (Invitro-
gen), following the manufacturer’s instructions.
Genomic DNA was isolated following the manufac-
turer’s instructions using a DNeasy
® Blood and Tissue Kit
(Qiagen) and was used as a positive control for all RT-
PCR experiments. PF11_0394 full-length gene specific pri-
mers (5’-atgaaaatttttaattacatatgtg-3’ forward and 5’-ttata-
taatatttctattatcttcc-3’ reverse) were used to amplify a 762
base pair (bp) gDNA fragment and a 561 bp cDNA frag-
ment in a polymerase chain reaction (PCR) using 2.0 μl
gDNA (~100 ng total)/cDNA (~1/10 the volume synthe-
sized from above), 1.25 units GoTaq
® DNA Polymerase
(Promega), 1X GoTaq
® Flexi Buffer, 1 mM MgCl2,
0.2 mM di-nucleotide tri-phosphate mix, and 0.5 μM pri-
mers. PCR conditions were as follows: an initial denaturing
step of 95°C for three minutes, 35 repetitive cycles of
denaturing at 95°C for 30 seconds, primer annealing at
56°C for 30 seconds and an extension at 62°C for three
minutes, and then a final extension at 62°C for 10 minutes
[18]. Plasmodium falciparum heat shock protein-70 was
used as a positive control during the axenic exoerythrocy-
tic stage studies since PF11_0394 transcript was not
detected and the primers used were 5’-aggtata-
gaaactgtgggtgg-3’ forward and 5’-gattggttggcatacagcttc-3’
reverse. After PCR amplification, all samples were sepa-
rated on a 1% agarose gel and stained with ethidium bro-
mide (EtBr) for UV detection. The experiments using
oocyst sporozoites and axenic exoerythrocytic stages were
done in biological duplicates. The experiments with sali-
vary gland sporozoites, mixed ES, and mixed gametocytes
were done in biological triplicates.
Creation of a PF11_0394/GFP-trafficking construct
To detect the presence of PF11_0394 protein throughout
the life cycle of the parasite, a PF11_0394/GFP-trafficking
construct was made by cloning base pairs 28-759 (exclud-
ing the stop codon) of the open reading frame of the gene
into the pPM2GT vector (obtained from MR4) [19]. The
primers used to amplify the region were 5’-ccgctcgagcgtc-
ctttaagaaatggtg-3’ forward and 5’-ccgcctaggtataatatttctat-
tatcttcc-3’ reverse. The restriction enzymes XhoI and
AvrII (New England Biolabs) are underlined and were
used for cloning into the pPM2GT vector. These primers
were used to amplify a 732 bp product via PCR using
2.0 μl DNA (~100 ng total), 1.0 μl FastStart High Fidelity
Taq Polymerase (5 U/μl Roche), 1X FastStart Buffer,
1m MM g C l 2, 0.2 mM di-nucleotide tri-phosphate mix,
and 0.5 μM primers. The PCR was conducted using condi-
tions previously described, but with an annealing tempera-
ture of 54°C [20].
The product was double-digested with XhoI and AvrII,
along with the pPM2GT vector, separated via gel electro-
phoresis, gel-purified according to the manufacturer’s
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® Gel Extraction Kit (Qiagen),
and ligated with T4 DNA Ligase (Promega) following the
manufacturer’s instructions. Two microlitres of the liga-
tion products were transformed into DH10B electrocom-
petant cells via electroporation and streaked on antibiotic
resistant plates. Using colonies that grew on the plates,
gDNA was isolated as previously described. The DNA was
sequenced at the DNA Core Facility at the University of
Missouri and aligned with the PF11_0394 sequence avail-
able from PlasmoDB using Vector NTI (Invitrogen) to
confirm that the correct protein coding sequence was
obtained.
Transfection of parasites with the trafficking construct
Transfections of P. falciparum were carried out according
to Crabb and colleagues [21]. Before performing the trans-
fections, mixed ES parasite cultures were synchronized
with 5% D-sorbitol (Sigma) for 10 minutes followed by
two washes with RPMI 1640 (Gibco) at 1,600 × g for five
minutes two days before transfection. In addition, plasmid
DNA was isolated using a Plasmid Maxi Kit (Qiagen) and
equilibrated in CytoMix (120 mM KCl, 0.15 mM CaCl2,
2 mM EGTA, 5 mM MgCl2,1 0m MK 2HPO4 pH 7.6, and
25 mM HEPES pH 7.6). The synchronized P. falciparum
ring stage NF54 parasites were electroporated (BTX 600,
BTX Harvard Apparatus; 0.2 cm cuvette, 0.31 kV, 950 μF,
maximum resistance) with 50 μg of the plasmid DNA in
CytoMix [21]. Transfected P. falciparum cultures were
maintained as previously described.
Two days following electroporation, media containing
WR99210 (2.5 nM, Sigma) was added to the cultures to
begin the process of selecting transfected parasites utiliz-
ing the human dihydrofolate reductase gene drug cassette
present in all constructs [21]. To enrich for GFP-traffick-
ing recombinants and eliminate episomal plasmids, para-
sites were subjected to at least three rounds of drug
selection (three weeks on drug and three weeks off drug
for each round).
To obtain a clonal population of parasites with no pre-
sence of wild-type parasites carrying episomes, a limiting
dilution was performed on the transfected parasites. Para-
sites were seeded in 96-well plates (200 μl volume) at two
concentrations, either 25% or 50% of wells would contain
a single parasite, and maintained in a gassed modular
incubator chamber (Billups-Rothenberg, Inc., 3% O2,3 %
CO2,a n d9 4 %N 2) at 37°C. Cultures were gassed every
other day for 20 days. On days 7, 14, and 17, 0.4% fresh
red blood cells were added. On day 20, 150 μl of the para-
site culture were transferred to a 96-well plate to begin
gDNA isolation for use in PCR and Southern blot analysis
to determine if clonal populations of parasites had been
successfully created. To isolate the gDNA, 50 μlo f6 %
saponin (Sigma) was added to the 150 μl of cultures in the
96-well plate and incubated for five minutes at RT. The
plate was centrifuged for 15 minutes at 2,650 × g and
supernatant removed. One hundred microlitres of 1X PBS
was added to each well to wash the parasites and the plate
was centrifuged as previously described. The 1X PBS was
removed and 40 μlo fd o w ns c a l ep r e pb u f f e r( D S P ,1M
Tris-Cl pH 8.0, 1 M KCl, and 1 M MgCl2) working stock
(985 μl DSP stock, 10 μl proteinase K, and 5 μl Tween 20)
was added to each well and parasite pellets re-suspended
in the DSP solution [22]. The plate was incubated for 30
minutes at 50°C and then for 10 minutes at 95°C. The
resulting gDNA was stored at 4°C until further use. The
remaining 50 μl of parasites were used for expansion and
cryopreservation of promising clonal parasite populations.
PCR and Southern blot verification of the GFP-trafficking
construct
Integration of the transfected DNA at the correct location
was verified for the PF11_0394/GFP clones by PCR and
Southern blot analysis. To verify integration at the
PF11_0394 locus by PCR, the primers 5’-atgaaaatttttaatta-
catatgtg-3’ PF11_0394 gene specific forward primer and
5’-tccgtatgttgcatcacc-3’ GFP reverse primer were used for
the GFP-trafficking construct and 4.0 μl gDNA (isolated
from the 96-well plates above), 1.25 units GoTaq
® DNA
Polymerase (Promega), 1X GoTaq
® Flexi Buffer, 1 mM
MgCl2, 0.2 mM di-nucleotide tri-phosphate mix, and
0.5 μM primers were used. PCR conditions were as fol-
lows: an initial denaturing step of 95°C for three minutes,
35 repetitive cycles of denaturing at 95°C for 30 seconds,
primer annealing at 52°C for 30 seconds and an extension
at 62°C for three minutes and 30 seconds, and then a final
extension at 62°C for 10 minutes. The samples were all
separated via gel electrophoresis (1% gel) and visualized
via UV detection using EtBr.
Southern blotting was performed with gDNA isolated as
previously described from ES parasites and DIG nonra-
dioactive nucleic acid labelling technology (Roche) was
used for visualization of the DNA. Genomic DNA (2-3 μg)
that was digested with SapI and KpnI was hybridized with
a 732 bp fragment of PF11_0394 created with the PCR
DIG Probe Synthesis Kit following the manufacturer’s
instructions (Roche). Before hybridization, the DNA was
separated on a 0.7% agarose gel and transferred to a posi-
tively charged nylon membrane (Osmonics) overnight via
an upward transfer method. Following the manufacturer’s
instructions, the membrane was washed, hybridized with
the above probes, and DNA products detected by autora-
diography using the DIG Nucleic Acid Detection Kit
(Roche).
GFP-trafficking studies
The GFP-trafficking studies described below were done
using two independent PF11_0394/GFP clones obtained
via the limiting dilution process previously described.
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cate, with a technical replicate conducted for each as
well.
Mixed erythrocytic stages and gametocytes
Both P. falciparum mixed ES cultures and day 16 mixed
gametocyte cultures were obtained by collecting 200 μlo f
infected blood from culture flaks. This protocol was fol-
lowed for all experimental groups: PF11_0394/GFP,
NF54 WT negative control parasites, and 3D7HT-GFP
(obtained from MR4) positive control parasites [23]. The
collected, infected blood was centrifuged for five minutes
at 2,650 × g and the supernatant removed. The infected
red blood cells (iRBCs) were re-suspended in 200 μl1 X
PBS containing DAPI nuclear stain (1:1,000 dilution,
Invitrogen) and incubated in the dark for five minutes at
RT. The iRBCs were centrifuged again for five minutes at
2,650 × g, washed once with 200 μl IX PBS, centrifuged a
final time for five minutes at 2,650 × g, and a small drop
of the blood was placed on a slide. Coverslips were placed
on the slides and they were viewed with a 100X objective
using an Olympus BX51 inverted fluorescent microscope
coupled with a X-Cite
® Series 120 fluorescent light
source. The entire slide was scanned, with at least 100
iRBCs and 50 gametocytes observed for each group.
Zygotes and ookinetes
For all experimental groups listed above, six mid-guts were
dissected from P. falciparum-infected An. stephensi 24-
30 hours PI. The mid-guts were placed in 1X PBS contain-
ing DAPI nuclear stain (1:1,000 dilution) and incubated at
RT for five minutes. The mid-guts were then placed three
per slide into 15 μlo fM a t r i g e l ™ (BD Biosciences) and
coverslips placed on top. The infected mid-guts were then
viewed as described above. Due to limited numbers, at
least nine zygotes and five ookinetes were observed for
each group per replicate.
Oocyst sporozoites
For all experimental groups listed above, six mid-guts were
dissected from P. falciparum-infected An. stephensi
10 days PI. The mid-guts were placed in 1X PBS contain-
ing DAPI nuclear stain (1:1,000 dilution) and incubated at
RT for five minutes. Three mid-guts per slide were then
placed into 15 μl of 1X PBS and coverslips placed on the
slides. The infected mid-guts were viewed as previously
described. At least 75% of the mid-guts had infections
with three-18 oocysts per mid-gut for each group.
Haemolymph sporozoites
Haemolymph sporozoites were collected by perfusing the
body cavity of 10 P. falciparum-infected An. stephensi 12
days PI with 1X PBS. Haemolymph for all experimental
groups described above was collected in microcentrifuge
tubes containing 40 μl 1X PBS with DAPI nuclear stain
(1:1,000 dilution). The sporozoites were concentrated by
centrifugation at 18,000 × g for five minutes, supernatant
removed, and 10 μl of sporozoites spotted on slides
containing 10 μlo fM a t r i g e l ™ [17]. Coverslips were
placed on top of the slides and they were viewed as
described above. Due to the difficulty of isolating haemo-
lymph sporozoites from An. stephensi,o n l yt h r e et of i v e
haemolymph sporozoites were observed for each group
per replicate.
Salivary gland sporozoites
For all three experimental groups, six pairs of salivary
glands were dissected from P. falciparum-infected An.
stephensi 13-20 days PI. The glands were placed in 1X
PBS containing DAPI nuclear stain (1:1,000 dilution) and
incubated at RT for five minutes. The glands were then
placed into 15 μl of 1X PBS on a slide and coverslips
placed on top. The infected salivary glands were viewed
as previously described. For each experimental condition,
at least 75% of the salivary glands were infected with
hundreds of sporozoites observed per set of infected
glands for each replicate.
Results and discussion
PF11_0394 sequence analysis
PF11_0394 is a 762 base pair (bp) gene on chromosome
eleven, containing one intron, resulting in a 561 bp cDNA
product. The cDNA product encodes a 186 amino acid
P. falciparum protein with an estimated molecular weight
of 21,026 Daltons. Initial PlasmoDB data, based upon
mass spectrometry results and sequence analysis, sug-
gested that the PF11_0394 protein was expressed by sali-
vary gland sporozoites, has a signal anchor, and four
transmembrane domains (amino acids 28-50, 65-84, 97-
119, and 149-171) [7,24]. To confirm these data and
obtain more information about PF11_0394, additional
sequence analysis programs were utilized. SignalP revealed
that PF11_0394 is predicted to have a non-cleavable signal
anchor [25]. Analysis using TargetP predicted that the
protein enters the secretory pathway and, more specifi-
cally, is predicted to be a plasma membrane protein
(located on the surface of the parasite) according to
PSORTII and WoLF PSORT [26,27]. Additional sequence
analysis using PROSITE, PROTCOMP, Profam, and NCBI
(BLASTp) sites predicted that the protein has no GPI-
anchor, has multiple glycosylation and phosphorylation
sites and has no functional identity with other known
proteins [16,28].
Next, PlasmoDB and results from a BLAST analysis
identified orthologs of PF11_0394 in other Plasmodium
species (Figure 1A). The PF11_0394 protein has homology
with proteins in P. vivax (Pv = PVX_092525 in PlasmoDB),
Plasmodium knowlesi (Pk = PKH_093600 in PlasmoDB),
Plasmodium reichenowi (Pr = c000130608.contig1 in San-
ger), Plasmodium berghei (Pb = PBANKA_091050 in Plas-
moDB), Plasmodium yoelii (Py = PY06419 in PlasmoDB),
Plasmodium chabaudi (Pc = PCHAS_071180 in Plas-
moDB), and Plasmodium gallinaceum (Pg = c000315856.
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Page 5 of 12Figure 1 PF11_0394 has orthologs in other Plasmodium species (A) and other Apicomplexans (B). BLAST analysis of PF11_0394 showed
that the protein has orthologs in other Plasmodium species (A), as well as other Apicomplexans (B); however, PF11_0394 does not have
orthologs with any proteins from members outside of the group Apicomplexa. Amino acids highlighted in yellow are identical in all proteins
and amino acids highlighted in blue are similar in a majority of the proteins. The PF11_0394 protein has homology with proteins in Plasmodium
vivax (Pv = PVX_092525 in PlasmoDB), Plasmodium knowlesi (Pk = PKH_093600 in PlasmoDB), Plasmodium berghei (Pb = PBANKA_091050 in
PlasmoDB), Plasmodium yoelii (Py = PY06419 in PlasmoDB), Plasmodium chabaudi (Pc = CHAS_071180 in PlasmoDB), Plasmodium reichenowi (Pr =
reich166f05 in Sanger), and Plasmodium gallinaceum (Pg = Pgal0546c06 in Sanger). The PF11_0394 protein also has orthologs with other
Apicomplexans, including Babesia bovis (Bb = BOV_I000760 in GenBank), Theilaria parva (Tp = XP_765419 in GenBank), Cryptosporidium hominus
(Ch = Chro.30131 in CryptoDB), and Toxoplasma gondii (Tg = 38.m02365 in ToxoDB).
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logs with other Apicomplexans (Figure 1B), including
Babesia bovis (Bb = BBOV_I000760 in GenBank),
Theilaria parva (Tp = XP_765419 in GenBank), Cryptos-
poridium hominus (Ch = Chro.30131 in CryptoDB), and
Toxoplasma gondii (Tg = 38.m02365 in ToxoDB). The
PF11_0394 protein does not appear to have any orthologs
with other proteins from members outside of the Apicom-
plexan group. PF11_0394 appears to be a highly conserved
p r o t e i nw i t h i nt h eg e n u sPlasmodium (79.6-98% conserved
when PF11_0394 is compared to its orthologs) and is also
conserved in several other Apicomplexans. Like PF11_
0394, the Plasmodium proteins listed here are all predicted
to have signal anchors (minus P. yoelii, whose sequence is
not complete), enter the secretory pathway, and are pre-
dicted to be plasma membrane proteins. In addition, the
proteins do not have any known function and/or identity
with known proteins, but based on their conserved identity
it is predicted that they would have similar functions in
Apicomplexan biology. Since PF11_0394 does not have
homology with any known human protein, it could be a
good target candidate for a new vaccine.
PF11_0394 transcript is present throughout a majority of
the Plasmodium falciparum life cycle
PF11_0394 transcript is present in oocyst sporozoites
(Figure 2A), salivary gland sporozoites (Figure 2B), mixed
erythrocytic stages (ES, cultures containing a mixture of
rings, trophozoites, and schizonts) (Figure 2C), and mixed
gametocyte stages (Figure 2D, cultures containing a mix-
ture of stage I-V gametocytes), as demonstrated via RT-
PCR (561 bp transcript). For all experiments, the gDNA
positive control amplified the correct intron-containing
product (762 bp) and the negative control (no reverse
transcriptase) did not amplify any products.
Since generating exoerythrocytic stage parasites using
primary human hepatocytes was not successful, a method
to produce exoerythrocytic stages using axenic cultures
(without the presence of liver cells) was utilized [12]. Data
obtained using the axenic exoerythrocytic stages suggest
that the PF11_0394 transcript is not present during exoer-
ythrocytic stages when compared to an exoerythrocytic
stage control gene, P. falciparum heat shock protein-70
(PfHsp70), which did amplify a transcript (Figure 2E). The
PfHsp70 gene was used as a positive control since its tran-
script is highly up-regulated in exoerythrocytic stage para-
sites, but barely detectable in sporozoites [12]. This result
indicated that exoerythrocytic stage parasites were indeed
produced in the axenic cultures. Genomic DNA was used
as a positive control and a no-reverse transcriptase reac-
t i o nw a su s e da san e g a t i v ec o n t r o la sd e s c r i b e da b o v e .
Primers specific to the P. falciparum circumsporozoite pro-
tein gene (PfCS) were also used in the RT-PCR (data not
shown). A transcript for PfCS was not amplified, even
though the gene and protein have been shown to be
expressed during the early exoerythrocytic stages [29].
This result demonstrates that even though axenic liver
stage parasites were generated, as indicated by the pre-
sence of PfHsp70 transcript, they were likely produced at
low levels. Therefore, the PF11_0394 transcript could
potentially be detected if greater parasite numbers were
present.
In addition to data available on PlasmoDB, a literature
search was conducted for PF11_0394 and its predicted
orthologs in two rodent malaria models, P. berghei and
P. yoelii, to assess previous transcript and protein detec-
tion data generated throughout the life cycle of the
parasite. According to the literature and PlasmoDB,
PF11_0394 transcript is present during the salivary
gland sporozoite stage and erythrocytic stages (specifi-
cally free merozoites, rings, trophozoites, schizonts, and
gametocytes) [5,30-33]. Transcript results for exoery-
throcytic stages vary between species, with a study in
P. falciparum indicating no transcript expression and
two studies, one using P. yoelii and one using P. berghei,
confirming transcript expression [34-36]. Data obtained
during these studies in P. falciparum for the salivary
gland sporozoite stage, exoerythrocytic stages, mixed
erythrocytic stages, and mixed gametocyte stages con-
firm results in the literature [5,30-36]. The presence of
PF11_0394 transcript in oocyst sporozoites has not been
described elsewhere and represents new knowledge
about the P. falciparum transcriptome.
The PF11_0394 protein is present in salivary gland
sporozoites, as demonstrated by GFP-trafficking studies
Several attempts to produce PF11_0394 recombinant
protein were employed, but were never successful. These
included the use of several types of bacterial expression
systems (Novagen), as well as a baculovirus expression
system (Invitrogen). When using these systems, the
PF11_0394 protein appeared to be expressed at low
levels, but it could never be purified (even in the presence
of protease inhibitors). Then, synthetic peptides were
produced, using a commercial source (Genscript), and
were used for IgY antibody production in chickens
(Avian Immunology). Unfortunately, the peptides proved
to be non-immunogenic, as the antibodies did not detect
any proteins following Western blot analysis or produce
any signals on immunofluorescent assays. PF11_0394
sequence analysis revealed that this protein has a signal
anchor and four transmembrane domains, resulting in a
largely hydrophobic protein embedded within the mem-
brane of the parasite [37]. Thus, this feature of the
PF11_0394 protein may have caused the protein produc-
tion techniques used to be unsuccessful. Therefore, a
PF11_0394/GFP-trafficking construct was created and
used for protein trafficking studies.
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throughout the life cycle of P. falciparum and confirm
data found in the literature, a PF11_0394/GFP trafficking
construct was created using the pPM2GT vector and
transfected into the genome of the parasite via homolo-
gous recombination technology (Figure 3A) [19]. After a
limiting dilution, two PF11_0394/GFP clones were iso-
lated after initial PCR analysis (Figure 3B) confirmed that
they had properly integrated into the genome of the para-
site and the populations lacked the presence of wild-type
(WT) parasites carrying episomes. These data were con-
firmed by Southern blot analysis (Figure 3C), as the pre-
dicted integration products of 10,454 base pairs and
6,602 base pairs were detected along with the absence of
WT parasites carrying episomes. A Southern blot pro-
duct of unknown origin was also detected and was likely
caused by a rearrangement of the plasmid that occurred
after transfection. This has been previously documented
with the pPM2Gt vector [19].
Using the two PF11_0394/GFP clones, two independent
GFP-trafficking studies were completed (with two techni-
cal replicates each). WT parasites were used as a negative
control and P. falciparum 3D7HT-GFP parasites constitu-
tively expressing GFP throughout the life cycle of the para-
site were used as a positive control [23]. The various
developmental stages of the parasite were examined using
fluorescent microscopy (Figure 4). The stages observed
were: mixed ES (contained a mixture of rings, tropho-
zoites, and schizonts), mixed gametocytes (induced for
16 days and contained a mixture of stages I-V male and
female gametocytes), zygotes (24 hours post infection, PI),
ookinetes (24-30 hours PI), oocyst sporozoites (eight-10
days PI), haemolymph sporozoites (12 days PI), and sali-
vary gland sporozoites (13-20 days PI). The PF11_0394
protein was not detected in mixed ES, mixed gametocyte
stages, zygotes, ookinetes, oocyt sporozoites, and haemo-
lymph sporozoites, despite a reasonable number of para-
sites being observed for each stage for each of the four
Figure 2 PF11_0394 transcript expression profile as shown by RT-PCR. Primers specific for PF11_0394 were used to amplify cDNA fragments
of the correct product size (RT+), indicating the presence of the transcript in oocyst sporozoites (A), salivary gland sporozoites (B), mixed
erythrocytic stages (C, containing a mixture of rings, trophozoites, and schizonts), and mixed gametocyte stages (D, containing a mixture of
stage I-V gametocytes). PF11_0394 transcript was not detected in axenic exoerythrocytic stages (E); however, primers specific to the Plasmodium
falciparum heat shock protein-70 (Hsp70) gene were used as a positive control to verify the presence of P. falciparum exoerythrocytic stages.
Genomic DNA (g+) was used as a positive control and a no reverse-transcriptase (RT-) reaction was used as a negative control to show that the
RNA was not contaminated with gDNA. PF11_0394 contains an intron, resulting in the size difference between gDNA and cDNA, and the arrows
indicate the PF11_0394 RT-PCR products. This figure is a representative image of all the biological replicates conducted. Sg = salivary gland and
ES = erythrocytic stages.
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Page 8 of 12replicates (see Methods). The PF11_0394 protein was only
detected in salivary gland sporozoites (200/200 = 100%
detection in salivary gland sporozoites counted, with hun-
dreds of additional parasites observed as well). For all
experiments, all of the 3D7HT-GFP parasites were positive
for GFP expression and all of the WT parasites were nega-
tive (the parasites did not express GFP). These data
confirm previous mass spectrometry results found by
Florens and colleagues and Lasonder and colleagues that
the PF11_0394 protein is present in salivary gland sporo-
zoites and not in other life cycle stages they observed,
which included gametes, salivary gland sporozoites, free
merozoites, trophozoites, schizonts and gametocytes
between the two groups [4,7]. These data also provide
 A. GFP-trafficking Schematic   
 
Vec - R 
GFP  -  trafficking 
Vector 
Target gene on    gDNA 
(Chromosome) 
Integration Event 
Vec  - F
hDHFR 
PF11_0394 
PF11_0394 
WGSP - F
WGSP - R 
WGSP - R 
WGSP - F 
Vec - F 
Vec  - R 
hDHFR 
GFP 
GFP 
PF11_0394 
Figure 3 Creation of two PF11_0394/GFP clonal parasite populations for protein trafficking studies. A) Transfection schematic
demonstrating how the PF11_0394/GFP construct was created using the pPM2GT vector (obtained from MR4) and successfully incorporated into
the genome of the parasite via homologous recombination technology [19]. Expression of GFP is driven by the endogenous promoter of
PF11_0394. Generation of two PF11_0394/GFP clonal parasite populations were verified by both PCR analysis (B) and Southern blot analysis using
digoxigenin (DIG) technology coupled with autoradiography (C). Arrows indicate the predicted integration products of 10,454 base pairs and
6,602 base pairs using a PF11_0394 specific probe after restriction digestion with SapI and KpnI. The product indicated by an asterisk is of
unknown origin and is likely a rearrangement of the plasmid that occurred after transfection. The drug cassette within the vector used for
positive selection is human dihydrofolate reductase (hDHFR). GFP = Green fluorescent protein, Wt = Wild-type parasite genomic DNA, Cl =
Clonal PF11_0494/GFP parasite genomic DNA, and Ep = PF11_0394/GFP plasmid DNA representing the episome. The arrows on the transfection
schematic represent primers used for PCR analysis.
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previously studied, such as the zygotes, ookinetes, oocyst
sporozoites, and haemolymph sporozoites.
Due to the difficulty of generating liver stage parasites
in vitro, protein detection studies were not able to be
conducted for PF11_0394 during this particular life
cycle stage. Nevertheless, based on data suggesting tran-
script is not present during the exoerythrocytic stages, it
is predicted that the PF11_0394 protein is not present
during the liver stages; however, there is always the pos-
sibility that the PF11_0394 protein is expressed during
the liver stages, especially early exoerythrocytic stage
development.
Attempts to generate a clonal population of mutant
PF11_0394 parasites to assess a potential function of
PF11_0394 were not successful
PF11_0394 gene disruption constructs were made for
functional analysis by cloning base pairs 37-700 of
PF11_0394 into both the pHD22y and pCAM-BSD vectors
[15,38,39]. Unfortunately, once the constructs were trans-
fected into P. falciparum, integration of the constructs was
Figure 4 PF11_0394/GFP-trafficking studies demonstrate that the PF11_0394 protein is present in salivary gland sporozoites.T h e
PF11_0394 protein is not detected during mixed erythrocytic stages (ES, culture representing a mixture of rings, trophozoites, and schizonts),
mixed gametocytes (culture representing a mixture of stage I-V gametocytes), zygotes, ookinetes, oocyst sporozoites, and haemolymph
sporozoites. The PF11_0394 protein is detected in salivary gland sporozoites. 3D7HT-GFP (3D7-GFP) constitutively expressing parasites were used
as a positive control and wild-type (WT) parasites were used as a negative control [23]. This figure is a representative image from two biological
replicates (one with each independent clone created) with two technical replicates each. Yellow arrowheads depict the presence of parasites
that lack GFP expression (merged images). GFP = green fluorescent protein and nuclear stain = DAPI. The black scale bar in the lower right
represents all of the images (except for the oocyst sporozoite stage) and is 10 μm. The yellow scale bar for the oocysts is 20 μm.
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drug selection. The PF11_0394 protein is not expressed in
mixed erythrocytic stage parasites (the stage of the life
cycle when transfections are conducted), so the failure to
obtain a mutant PF11_0394 parasite population was not
likely due to it being essential during this life cycle stage.
The lack of integration could be due to the genome of
P. falciparum being highly AT-rich (~80%) with greater
than 90% of it occurring in the intronic regions of the gen-
ome [40]. Because PF11_0394 has one intron, it is a possi-
bility that when the PF11_0394 disruption constructs were
transfected into the P. falciparum genome, the highly AT-
rich intron of PF11_0394 may have caused the constructs
to homologously recombine with either other AT-rich
areas of the P. falciparum genome or perhaps, with
another gene that has an intron of similar sequence.
Conclusions
In summary, data obtained from these studies demonstrate
that PF11_0394 is a P. falciparum protein that has ortho-
logs in other Plasmodium species and also has orthologs
with other Apicomplexans. PF11_0394 does not have
orthologs with any protein outside of the Apicomplexan
group and shares no functional identity with other known
proteins. PF11_0394 is thus a novel protein to study in
P. falciparum biology. Transcript detection studies deter-
mined that PF11_0394 transcript is present throughout a
majority of the life cycle of the parasite, including mixed
ES, mixed gametocyte stages, oocyst sporozoites, and sali-
vary gland sporozoites, but is not detectable during axenic
exoerythrocytic stages. Protein detection studies demon-
strated that the PF11_0394 protein is present in salivary
gland sporozoites and not in other stages examined.
Overall, these data obtained for PF11_0394 have deter-
mined that the PF11_0394 protein is present in salivary
gland sporozoites and, therefore, may be required for para-
site or sporozoite development/survival in the mosquito
salivary glands and/or development within and/or invasion
of human host tissues. A few Plasmodium sporozoite pro-
teins have been found to be critical for development and/
or invasion of host tissues. For example, both the CS pro-
tein and TRAP are sporozoite proteins that are essential
for proper development and invasion of both mosquito
salivary glands and human hepatocytes [9,10,41-45]. Thus,
based on the protein detection profile of PF11_0394, it
could be another candidate gene for a pre-erythrocytic
stage vaccine since it does not share identity with any
known human protein.
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